ClinicalTrials.gg
Active, not recruitingNCT07788443Updated Aug 26, 2026

V-CAF Technique for Miller Class III Gingival Recession

An interventional study of Vertically coronally advanced flap (V-CAF) in Gingival Recession and Gum Recession, sponsored by University of Medicine and Pharmacy at Ho Chi Minh City. Active, not recruiting at 1 site in Vietnam. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-08-26.

Sponsored by University of Medicine and Pharmacy at Ho Chi Minh City · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 1 year 6 months after the study started (first participant enrolled Feb 2025, registered Aug 2026).
Phase
Not applicable
Study type
Interventional
Enrollment
25
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

The purpose of this clinical trial is to evaluate the effectiveness of a modified surgical technique called the vertically coronally advanced flap (V-CAF) combined with a connective tissue graft and tissue regeneration for treating gingival recession. For more severe cases (Miller Class III), the study investigates the relationship between the pre-operative Coronally Advanced Flap Difficulty Score (CAFDS) and post-operative outcomes, such as the root coverage rate and interdental papilla height. Participants will undergo the assigned surgical treatment and will be followed up at 3, 6, and 12 months to assess healing and tissue stability.

Read the detailed description

Gingival recession is a condition that causes root exposure, which can lead to dentin hypersensitivity and aesthetic concerns.

Initially, the study describes the clinical characteristics and factors associated with gingival recession utilizing clinical examinations, 3D intraoral scans, and Cone Beam Computed Tomography (CBCT).

The interventional surgical phase is the single-arm clinical trial involving Twenty-five Miller Class III gingival recession sites. This phase evaluates the correlation between the pre-operative Coronally Advanced Flap Difficulty Score (CAFDS) and clinical outcomes, specifically evaluating the root coverage percentage and interdental papilla height using the V-CAF technique. Standardized clinical parameters, including Recession Depth (RD), Keratinized Tissue (KT) height, Gingival Thickness (GT), Vestibular Depth (RVD), and the Root Coverage Esthetic Score (RES) will be recorded. Data will be collected at baseline (T0), 3 months (T3), 6 months (T6), and 12 months (T12) post-surgery to conduct comparative analyses.

02

Conditions studied

  • Gingival Recession
  • Gum Recession

Browse trials for

Keywords

  • Coronally Advanced Flap
  • V-CAF
  • Connective Tissue Graft
  • Tissue Regeneration
  • Miller Class III
03

In context

Gingival Recession

426 studies on the registry are indexed under Gingival Recession; 106 are open to participants now.

This study's enrollment of 25 is below the median of 30 across 390 interventional studies indexed under Gingival Recession.

Browse Gingival Recession studies →

Lead sponsor

University of Medicine and Pharmacy at Ho Chi Minh City is the lead sponsor of 127 studies on the registry; 44 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients aged 18 years or older
  • Systemically healthy (no systemic diseases) and not pregnant
  • Non-smokers
  • Presence of at least one tooth presenting with Miller Class III gingival recession with a recession depth of ≥ 2 mm
  • Medium or thin gingival biotype

Exclusion criteria

Exclusion Criteria:

  • History of periodontal treatment or mucogingival/periodontal surgery at the study site
  • Presence of fixed prosthesis on the tooth with gingival recession
  • Teeth with rotation or crowding
  • Presence of occlusal trauma
  • Active or progressive periodontitis
  • Patients who fail to attend follow-up visits or demonstrate non-compliance with post-operative care instructions
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
25 participants (actual)

Study arms

  • Experimental
    V-CAF Group

    Participants with Miller Class III gingival recession receiving the vertically coronally advanced flap (V-CAF) procedure

    Procedure: Vertically coronally advanced flap (V-CAF)

Interventions

  • ProcedureVertically coronally advanced flap (V-CAF)

    A surgical procedure utilizing a vertically coronally advanced flap combined with an autogenous connective tissue graft and tissue regeneration materials to treat gingival recession.

06

What researchers measure

Primary outcomes

  1. Mean Root Coverage (MRC)

    The mean percentage of root surface coverage achieved following treatment, assessed by measuring the root coverage area on intraoral scan files using digital measurement software

    Time frame: Baseline, 3 months, and 6 months after surgery

  2. Coronally Advanced Flap Difficulty Score (CAFDS)

    The Coronally Advanced Flap Difficulty Score (CAFDS) will be used to assess the anatomical difficulty of treating gingival recession defects with a coronally advanced flap. The score consists of eight anatomical parameters: papilla anatomy, apical keratinized tissue width, lateral keratinized tissue width, apical frenum, lateral frenum, vestibular depth, mucosal invagination, and scar tissue. Each parameter is assessed and assigned a predefined score according to the CAFDS system, with higher scores indicating greater surgical difficulty.

    Time frame: Baseline (T0), before surgery

Secondary outcomes

  1. Gingival Recession Depth (RD)

    The distance from the cementoenamel junction (CEJ) to the free gingival margin (FGM)

    Time frame: Baseline, 3 months, 6 months, and 12 months post-operative (T0, T3, T6, T12)

  2. Gingival Recession Width (RW)

    The horizontal distance between the two intersection points of the free gingival margin and the cementoenamel junction (CEJ)

    Time frame: Baseline, 3 months, 6 months, and 12 months post-operative (T0, T3, T6, T12)

  3. Base of the Interdental Papilla (IPb)

    A linear segment connecting the most apical points of the CEJ of the two adjacent teeth, intersecting the interdental papilla

    Time frame: Baseline, 3 months, 6 months, and 12 months post-operative (T0, T3, T6, T12)

  4. Interdental Papilla Height (IPh)

    The vertical distance from the base of the interdental papilla to the tip of the interdental papilla

    Time frame: Baseline, 3 months, 6 months, and 12 months post-operative (T0, T3, T6, T12)

  5. Interdental Papilla Width (IPw)

    The length of a horizontal line parallel to the base of the interdental papilla, located 2 mm apical to the papillary tip

    Time frame: Baseline, 3 months, 6 months, and 12 months post-operative (T0, T3, T6, T12)

  6. Keratinized Tissue Height (KT)

    The apicocoronal dimension of the keratinized gingival tissue

    Time frame: Baseline, 3 months, 6 months, and 12 months post-operative (T0, T3, T6, T12)

  7. Gingival Thickness (GT)

    The horizontal distance from the gingival surface to the root/alveolar bone surface, measured at 2 mm apical to the free gingival margin

    Time frame: Baseline, 3 months, 6 months, and 12 months post-operative (T0, T3, T6, T12)

  8. Vestibular Depth (RVD)

    The vertical distance from the free gingival margin to the depth of the vestibule

    Time frame: Baseline, 3 months, 6 months, and 12 months post-operative (T0, T3, T6, T12)

  9. Root Coverage Esthetic Score (RES)

    The professional esthetic evaluation score of the root coverage outcome

    Time frame: 3 months, 6 months, and 12 months post-operative (T3, T6, T12)

  10. Area of Gingival Recession

    The total exposed root surface area

    Time frame: Baseline, 3 months, 6 months, and 12 months post-operative (T0, T3, T6, T12)

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Feb 2025 (actual). Primary completion is estimated for Dec 2026, 22 months after the start.

Of 233 non-industry interventional studies with no phase under Gingival Recession, half reached primary completion within 19 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 30. This study's planned 22 months is above that.

Counting every sponsor, half of 235 studies reached it within 19 months; a quarter within 11 and three quarters within 30.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 23, 2026
First posted
Aug 26, 2026
StartActual
Feb 1, 2025
Primary completionEst.
Dec 25, 2026
CompletionEst.
Dec 25, 2026
Last update
Aug 26, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 26, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07788443
Responsible party
Nguyen Thu Thuy (Associate Professor, University of Medicine and Pharmacy at Ho Chi Minh City) — Principal investigator
First posted
Aug 26, 2026
Start date
Feb 1, 2025
Primary completion
Dec 25, 2026 (estimated)
Completion
Dec 25, 2026 (estimated)
Last update
Aug 26, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion